# NORGESTREL AND ETHINYL ESTRADIOL
> **ANDA202875** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2017-05-08
## Drug
- **FDA Application Number:** ANDA202875
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NORGESTREL AND ETHINYL ESTRADIOL
- **Generic name:** Ethinyl Estradiol
- **Active ingredients:** ETHINYL ESTRADIOL; NORGESTREL
- **Dosage form:** TABLET
- **Route:** ORAL-28
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN LABS LTD
- **First approval:** 2017-05-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202875)
---
*AI Analytics · CC0 1.0*